|
GB1244696A
(en)
|
1968-06-20 |
1971-09-02 |
Fuji Photo Film Co Ltd |
Improvements in colour developer compositions
|
|
US4559157A
(en)
|
1983-04-21 |
1985-12-17 |
Creative Products Resource Associates, Ltd. |
Cosmetic applicator useful for skin moisturizing
|
|
LU84979A1
(fr)
|
1983-08-30 |
1985-04-24 |
Oreal |
Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux
|
|
US4820508A
(en)
|
1987-06-23 |
1989-04-11 |
Neutrogena Corporation |
Skin protective composition
|
|
US4786644A
(en)
*
|
1987-11-27 |
1988-11-22 |
Hoechst-Roussel Pharmaceuticals Inc. |
1-aryl-3-quinolinecarboxamide
|
|
US4992478A
(en)
|
1988-04-04 |
1991-02-12 |
Warner-Lambert Company |
Antiinflammatory skin moisturizing composition and method of preparing same
|
|
US4938949A
(en)
|
1988-09-12 |
1990-07-03 |
University Of New York |
Treatment of damaged bone marrow and dosage units therefor
|
|
CN1087725C
(zh)
|
1994-03-25 |
2002-07-17 |
同位素技术有限公司 |
用氘代方法增强药物效果
|
|
US6334997B1
(en)
|
1994-03-25 |
2002-01-01 |
Isotechnika, Inc. |
Method of using deuterated calcium channel blockers
|
|
DE19834044A1
(de)
|
1998-07-29 |
2000-02-03 |
Bayer Ag |
Neue substituierte Pyrazolderivate
|
|
AU1324300A
(en)
*
|
1998-10-26 |
2000-05-15 |
Vertex Pharmaceuticals Incorporated |
Pentacyclic compounds useful as inhibitors of hepatitis c virus ns3 helicase
|
|
GB9902455D0
(en)
|
1999-02-05 |
1999-03-24 |
Zeneca Ltd |
Chemical compounds
|
|
US20040009613A1
(en)
*
|
2001-02-16 |
2004-01-15 |
Ming-Ming Zhou |
Methods of identifying modulators of bromodomains
|
|
TWI262920B
(en)
|
2000-10-27 |
2006-10-01 |
Elbion Ag |
New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them
|
|
US7666867B2
(en)
|
2001-10-26 |
2010-02-23 |
University Of Connecticut |
Heteroindanes: a new class of potent cannabimimetic ligands
|
|
SG176310A1
(en)
*
|
2001-11-08 |
2011-12-29 |
Ortho Mcneil Pharm Inc |
Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
|
|
US20050209252A1
(en)
*
|
2002-03-29 |
2005-09-22 |
Che-Ming Teng |
Cancer treatment
|
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
|
JP2007508363A
(ja)
*
|
2003-10-14 |
2007-04-05 |
オキサジェン リミテッド |
Ｃｒｔｈ２アンタゴニスト活性を有する化合物
|
|
WO2005037845A1
(en)
*
|
2003-10-17 |
2005-04-28 |
Rigel Pharmaceuticals, Inc. |
Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors
|
|
EP1722767A2
(en)
|
2004-02-23 |
2006-11-22 |
Prolexys Pharmaceuticals, Inc. |
NON-PEPTIDYL AGENTS WITH pHSP20-LIKE ACTIVITY, AND USES THEREOF
|
|
TW200612918A
(en)
|
2004-07-29 |
2006-05-01 |
Threshold Pharmaceuticals Inc |
Lonidamine analogs
|
|
US20070043057A1
(en)
*
|
2005-02-09 |
2007-02-22 |
Threshold Pharmaceuticals, Inc. |
Lonidamine analogs
|
|
ATE503476T1
(de)
*
|
2004-10-21 |
2011-04-15 |
Burnham Inst |
Zusammensetzungen und verfahren zur behandlung von krankheiten, die durch infektion mit yersinia spp ausgelöst sind
|
|
WO2008042571A2
(en)
|
2006-09-29 |
2008-04-10 |
Smithkline Beecham Corporation |
Substituted indole compounds
|
|
EP2089355A2
(en)
|
2006-11-01 |
2009-08-19 |
Brystol-Myers Squibb Company |
Modulators of glucocorticoid receptor, ap-1, and/or nf- kappa b activity and use thereof
|
|
US7858645B2
(en)
|
2006-11-01 |
2010-12-28 |
Hoffmann-La Roche Inc. |
Indazole derivatives
|
|
EP2120932B1
(en)
|
2006-12-20 |
2014-07-09 |
Nerviano Medical Sciences S.r.l. |
Indazole derivatives as kinase inhibitors for the treatment of cancer
|
|
WO2008089310A2
(en)
|
2007-01-18 |
2008-07-24 |
Lexicon Pharmaceuticals, Inc. |
Delta 5 desaturase inhibitors for the treatment of obesity
|
|
WO2008129276A1
(en)
|
2007-04-19 |
2008-10-30 |
Boehringer Ingelheim International Gmbh |
Disulfonamides useful in the treatment of inflammation
|
|
CA2707009A1
(en)
*
|
2007-11-21 |
2009-06-04 |
Cornell University |
Methods for inhibiting fascin
|
|
US8642660B2
(en)
*
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
EP2223421B1
(en)
|
2007-12-21 |
2015-01-21 |
SanDisk Technologies Inc. |
Self-configurable multi-regulator asic core power delivery
|
|
CU20080028A6
(es)
*
|
2008-02-29 |
2011-02-24 |
Ct Ingenieria Genetica Biotech |
Compuestos químicos obtenidos in silico para la preparación de composiciones farmacéuticas para atenuar o inhibir la infección por virus dengue y otros flavivirus
|
|
EP2257340A2
(en)
|
2008-04-04 |
2010-12-08 |
BioMarin IGA Limited |
Compounds for treating muscular dystrophy
|
|
CA2726987C
(en)
*
|
2008-06-04 |
2014-02-18 |
Baylor College Of Medicine |
Stat3 inhibitors
|
|
WO2010005534A2
(en)
*
|
2008-06-30 |
2010-01-14 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Proteasome inhibitors for selectively inducing apoptosis in cancer cells
|
|
US20110218158A1
(en)
|
2008-09-22 |
2011-09-08 |
Harris Reuben S |
Dna cytosine deaminase inhibitors
|
|
JO3101B1
(ar)
|
2008-12-02 |
2017-09-20 |
Takeda Pharmaceuticals Co |
مشتقات بنزوثيازول كعوامل مضادة للسرطان
|
|
WO2010102286A2
(en)
*
|
2009-03-06 |
2010-09-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Proteasome inhibitors having chymotrypsin-like activity
|
|
WO2011006158A2
(en)
*
|
2009-07-10 |
2011-01-13 |
University Of Maryland, Baltimore |
Targeting nad biosynthesis in bacterial pathogens
|
|
ES2360783B1
(es)
*
|
2009-10-02 |
2012-07-04 |
Consejo Superior De Investigaciones Científicas (Csic) |
1,2,4-tiadiazoles-5-imino sustituidos utiles en el tratamiento de enfermedades neurodegenerativas
|
|
KR101632318B1
(ko)
|
2009-11-05 |
2016-06-27 |
재단법인 의약바이오컨버젼스연구단 |
벤조헤테로사이클 유도체 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 암 예방 및 치료용 조성물
|
|
EP3138838A1
(en)
*
|
2010-01-29 |
2017-03-08 |
Dana-Farber Cancer Institute, Inc. |
Small molecules for the modulation of mcl-1 and methods of modulating cell death, cell division, cell differentiation and methods of treating disorders
|
|
WO2011133862A1
(en)
*
|
2010-04-23 |
2011-10-27 |
Oregon Health And Science University |
Methods and compositions for promoting myelination
|
|
DE102010040233A1
(de)
|
2010-09-03 |
2012-03-08 |
Bayer Schering Pharma Aktiengesellschaft |
Bicyclische Aza-Heterocyclen und ihre Verwendung
|
|
US20140031547A1
(en)
|
2010-12-14 |
2014-01-30 |
Electrophoretics Limited |
CASEIN KINASE 1delta (CK 1delta) INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODE-GENERATIVE DISEASES SUCH AS TAUOPATHIES
|
|
ES2618812T3
(es)
|
2011-01-20 |
2017-06-22 |
Merck Sharp & Dohme Corp. |
Antagonistas del receptor mineralocorticoide
|
|
HUE037312T2
(hu)
|
2012-12-19 |
2018-08-28 |
Celgene Quanticel Res Inc |
Hiszton demetiláz inhibitorok
|